DOI: 10.1055/s-00000069

Seminars in Liver Disease

References


An open-label, randomized phase 3 study of the efficacy and tolerability of linifanib (ABT-869) versus sorafenib in subjects with advanced hepatocellular carcinoma (HCC).
Available at:
http://clinicaltrials.gov/ct2/show/NCT01009593 . Accessed January 11, 2012

Download Bibliographical Data

Search in: